Back | Next |
home / stock / ovid / ovid message board
Subject | By | Source | When |
---|---|---|---|
* * $OVID Video Chart 03-03-2021 * * | ClayTrader | investorshub | 03/03/2021 9:03:35 PM |
* * $OVID Video Chart 03-03-2021 * * | ClayTrader | investorshub | 03/03/2021 9:03:35 PM |
Curling back up..lets best that intraday high of | Actualfactual | investorshub | 03/03/2021 6:22:49 PM |
Curling back up..lets best that intraday high of | Actualfactual | investorshub | 03/03/2021 6:22:49 PM |
Looks like a 20 dollar stock soon manipulation | Mamameloconto | investorshub | 03/03/2021 4:57:52 PM |
Looks like a 20 dollar stock soon manipulation | Mamameloconto | investorshub | 03/03/2021 4:57:52 PM |
$OVID is screaming for the top after the | AlphaStockNews | investorshub | 03/03/2021 1:24:57 PM |
$OVID is screaming for the top after the | AlphaStockNews | investorshub | 03/03/2021 1:24:57 PM |
$OVID | FROZENFLAME | investorshub | 12/17/2020 10:58:10 AM |
$OVID | FROZENFLAME | investorshub | 12/17/2020 10:58:10 AM |
Nice, $3s very possible today . | FROZENFLAME | investorshub | 12/16/2020 6:19:00 PM |
Nice, $3s very possible today . | FROZENFLAME | investorshub | 12/16/2020 6:19:00 PM |
$BCLI, I made out so far on selling | stoner422 | investorshub | 12/05/2020 2:02:04 PM |
$BCLI, I made out so far on selling | stoner422 | investorshub | 12/05/2020 2:02:04 PM |
The company still at strong buy, by 7 | FROZENFLAME | investorshub | 12/02/2020 11:17:22 PM |
The company still at strong buy, by 7 | FROZENFLAME | investorshub | 12/02/2020 11:17:22 PM |
Ive seen some play like this and they | FROZENFLAME | investorshub | 12/02/2020 11:07:22 PM |
Ive seen some play like this and they | FROZENFLAME | investorshub | 12/02/2020 11:07:22 PM |
Thats good enough for me . | FROZENFLAME | investorshub | 12/02/2020 10:48:33 PM |
Thats good enough for me . | FROZENFLAME | investorshub | 12/02/2020 10:48:33 PM |
News, Short Squeeze, Breakout and More Instantly...
Ovid Therapeutics Inc. Company Name:
OVID Stock Symbol:
NASDAQ Market:
Ovid Therapeutics Inc. Website:
Neurologists/epileptologists Dr. Imad Najm of the Cleveland Clinic Neurological Institute and the Cleveland Clinic Epilepsy Center, and Dr. Raman Sankar, the Emeritus Chief of Pediatric Neurology at UCLA Health, appointed to Ovid’s Scientific Advisory Board (SAB) Neuroscientists Dr. Ja...
Sustained exposure to OV329 in preclinical models reduced GABA-aminotransferase (GABA-AT) activity, increased steady state GABA levels in the brain, and induced phasic and tonic inhibition OV329 demonstrated anti-convulsant effects in mice, reducing the severity of status epilepticus and pr...
The Phase 1 study for OV888/GV101 capsule met its objective, demonstrating a favorable safety and tolerability profile with no serious adverse events Secondary endpoint results indicate that the target pharmacokinetic profile was achieved at the targeted clinical dose, supporting once daily d...